A Preview of Early-Stage Medical Technology Companies”
The Hyatt Regency, Irvine, California
Industry Panel Discussion
Alternatives to Traditional Venture Capital
February 27, 2007
Thomas J. Fogarty is an internationally recognized cardiovascular
surgeon, inventor, entrepreneur, and vintner. He has been involved
with a wide spectrum of innovations in business and technology, serving
as founder/co-founder, and Chairman/Board Member of over 33 various
business and research companies, based on devices designed and developed
by Fogarty Engineering, Inc. During the past 40 years, he has acquired
over 100 surgical patents, including the “industry standard”
Fogarty balloon embolectomy catheter and the widely used Aneurx Stent
Graft that replaces open-heart abdominal aortic aneurysm (AAA) surgery.
Dr. Fogarty is the recipient of countless awards and honors; most
significantly, he is the recipient of the Jacobson Innovation Award
of the American College of Surgeons, the 2000 Lemelson-MIT prize for
Invention and Innovation and was inducted into the Inventors Hall
of Fame in December 2001.
Fogarty was born in Cincinnati, Ohio and received his undergraduate
education at Xavier University and his medical degree from the University
of Cincinnati. He completed his residency at the University of Oregon
and later served as Medical Staff President at Stanford Medical
Center from 1973-1975. After thirteen years directing the Cardiovascular
Surgery Program at Sequoia Hospital, Redwood City, California, he
returned to academic life at Stanford University School of Medicine
in July 1993, as Professor of Surgery. He has a wide range of interests
that involve technology related procedures, devices, and services.
Werdegar, Investment Partner, Western Technology Investment
Werdegar joined WTI in 2001. He has worked on several dozen life science
investments including Acufocus, Cameron Health, Evalve, Inogen, MyoScience,
Oculus Innovative Sciences, ROX Medical, SenoRx, Tercica, VeinRx and
Volcano. He is also a member of the Life Science Angels, a Bay Area
based angel investment group. Maurice has worked previously as a Venture
Partner at Outlook Ventures, an early stage venture firm, and as Chief
Investment Officer at MetaMarkets, an online mutual fund company.
Mr. Werdegar also founded and served as CEO of Left at Albuquerque,
a chain of restaurants. Prior to business school, Mr. Werdegar worked
in corporate finance at Robertson Stephens. He holds both a BA and
an MBA from Stanford.
from the Buy Side: Buying Companies and Acquiring Technology
February 28, 2007
McDonough, President, Cytyc Development Corporation
McDonough is President of Cytyc Development Corporation having overall
responsibility for the development and execution of Cytyc’s
strategy focused on mergers & acquisitions, development and
marketing alliances and venture investing. Since joining Cytyc in
2003, he has lead the successful acquisition and integration of
several companies that now contribute over 35% of Cytyc’s
corporation’s annual revenue which was over $600 million in
came to Cytyc after serving as co-founder, CEO and president at
SoundBite Communications, a customer communications company. Previously,
he was COO of Direct Hit Technologies, an Internet search engine
company that was successfully acquired in January, 2000, and CEO
and President of Workgroup Technology, a publicly held company that
developed and marketed product development management solutions
for medical technology and pharmaceutical companies. John also spent
10 years with Easel Corporation where he held the role of CFO, COO
and then CEO of a start-up company that grew into a publicly held
company in 1990 and was acquired in 1995.
is a Certified Public Accountant and was a Senior Accountant with
Deloitte, Haskins and Sells after graduating Magna cum Laude from
Stonehill College in 1981.
Norman R. Sanders, M.D.
Vice President, Corporate Development and
Chief Medical Officer
Sanders serves as vice president, corporate development and chief
medical officer of Arthrocare. He has responsibility for the companies
strategic plan as well as corporate development efforts. In addition
he, along with the CEO and CFO, provide for investor relations, and
he assists the strategic business units in their marketing efforts.
Arthrocare in early 2001 working with the Spine business unit. He
was promoted to medical director of Arthrocare in 2002, and vice
president in 2004. He has worked on a number of acquisitions including
orthopedic company OPUS Medical, spine company Parallax Medical,
ENT company Applied Therapeutics, as well as other partnerships
and license agreements. Sanders received his doctor of medicine
degree from the University of California, San Francisco, where he
also did his postgraduate training in surgery and anesthesiology.
Prior to entering business he practiced anesthesiology in the San
Francisco Bay Area, and served as CDR, Medical Corps, USNR. He served
as an assistant clinical professor of anesthesiology at the San
Francisco General Hospital, and adjunct professor of combat casualty
care in the U.S. Navy.
John F. Nealon
Senior Vice President, Business Development
F. Nealon, 43, has served as Senior Vice-President of Business Development
since April 2005. From January 2002 to April 2005, he served as Vice-President
of Global Marketing at AMS. Mr. Nealon has over 15 years of experience
in the medical device industry. From 1996 to 2001, he served on the
management team at Survivalink, a start-up medical device company
which developed and marketed automated external defibrillators (AEDs).
His final three years at Survivalink, he served as Vice-President,
Marketing and International Sales. In 1996, he served as Director
of Product Marketing for Summit Medical. From 1989 to 1996, he served
in a variety of global product marketing roles at GE Medical Systems
in the x-ray, surgery and cardiology businesses. Mr. Nealon holds
a B.S. in Chemical Engineering from Northwestern University and an
MBA from the Kellogg School of Management (Northwestern University).
WEST conference page.